Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00570_DB01211_nanopub.RAqZrdGbF4QApPNnqrwuCkNP0-eBps6ttkDZLivLtSPTA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00570_DB01211 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00570_DB01211 label "DDI between Vinblastine and Clarithromycin - Clarithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinblastine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Clarithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00570_DB01211]" assertion.
- drugbank_resource:DB00570_DB01211 identifier "drugbank_resource:DB00570_DB01211" assertion.
- drugbank_resource:DB00570_DB01211 title "DDI between Vinblastine and Clarithromycin - Clarithromycin, a CYP3A4 and p-glycoprotein inhibitor, may increase the Vinblastine serum concentration and distribution in certain cells. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Clarithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00570 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB01211 assertion.
- drugbank:DB01211 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB01211 assertion.